Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...

Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Stream Connecticut News for free, 24/7, wherever you are. Drugmakers have poured billions of dollars into ...

Enhertu isn’t a typical chemotherapy or immunotherapy drug but rather a combination of chemotherapy and targeted therapy, known as an antibody-drug conjugate. Enhertu works by using an antibody to ...

Some chemotherapy drugs cause more damage to healthy cells than other chemo options do, a new study finds. The researchers have found four new mutational signatures — patterns of DNA damage left by ...

Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient breaks first. For decades, chemotherapy has walked that razor’s edge, saving ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

Most people who undergo chemotherapy do not develop heart failure. However, specific chemotherapy drugs may significantly increase your risk of heart failure and other cardiac problems. Chemotherapy ...

Cancer patients undergoing chemotherapy may soon have a new option to try to keep their hair — a shampoo-like gel that could protect hair from falling out during chemo. Baldness from ...

Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Drugmakers have poured billions of dollars into developing ADCs. The medicines are designed to deliver potent ...

Antibody-drug conjugates (ADCs) have taken major strides in recent years, as companies including AstraZeneca, Daiichi Sankyo, Pfizer and Merck are developing drugs in the space that could ease the ...

But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects in some cases. Antibody-drug conjugates ...